Aamand R, Dalsgaard T, Jensen FB, Simonsen U, Roepstorff A, Fago A. Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation. Am J Physiol Heart Circ Physiol 297: H2068 -H2074, 2009. First published October 9, 2009 doi:10.1152/ajpheart.00525.2009In catalyzing the reversible hydration of CO 2 to bicarbonate and protons, the ubiquitous enzyme carbonic anhydrase (CA) plays a crucial role in CO2 transport, in acid-base balance, and in linking local acidosis to O2 unloading from hemoglobin. Considering the structural similarity between bicarbonate and nitrite, we hypothesized that CA uses nitrite as a substrate to produce the potent vasodilator nitric oxide (NO) to increase local blood flow to metabolically active tissues. Here we show that CA readily reacts with nitrite to generate NO, particularly at low pH, and that the NO produced in the reaction induces vasodilation in aortic rings. This reaction occurs under normoxic and hypoxic conditions and in various tissues at physiological levels of CA and nitrite. Furthermore, two specific inhibitors of the CO2 hydration, dorzolamide and acetazolamide, increase the CA-catalyzed production of vasoactive NO from nitrite. This enhancing effect may explain the known vasodilating effects of these drugs and indicates that CO 2 and nitrite bind differently to the enzyme active site. Kinetic analyses show a higher reaction rate at high pH, suggesting that anionic nitrite participates more effectively in catalysis. Taken together, our results reveal a novel nitrous anhydrase enzymatic activity of CA that would function to link the in vivo main end products of energy metabolism (CO2/H ϩ ) to the generation of vasoactive NO. The CA-mediated NO production may be important to the correlation between blood flow and metabolic activity in tissues, as occurring for instance in active areas of the brain. acetazolamide; dorzolamide; acidosis; neurovascular coupling CARBONIC ANHYDRASE (CA) is a zinc-containing ubiquitous enzyme present in numerous isoforms (27, 42) catalyzing the reversible hydration of the major end product of aerobic metabolism, carbon dioxide (CO 2 ), into carbonic acid, forming bicarbonate (HCO 3 Ϫ ) and a proton:
acetazolamide; dorzolamide; acidosis; neurovascular coupling CARBONIC ANHYDRASE (CA) is a zinc-containing ubiquitous enzyme present in numerous isoforms (27, 42) catalyzing the reversible hydration of the major end product of aerobic metabolism, carbon dioxide (CO 2 ), into carbonic acid, forming bicarbonate (HCO 3 Ϫ ) and a proton:
Besides having a fundamental role in acid-base homeostasis and in electrolyte balance (42) , CA also effectively links blood O 2 delivery to metabolic CO 2 production from tissues. In being one of the fastest enzymes known (27) , CA in red blood cells is able to generate a local decrease in pH due to CO 2 hydration in the short transit time (Ͻ0.5 s) (47) of blood in the capillaries of active tissues. This local acidosis decreases the O 2 affinity of the hemoglobin through the Bohr effect, so that more O 2 is unloaded to active tissues at a constant O 2 tension (20, 30, 46) . Although numerous inhibitors of CA have been identified (29, 42) , CO 2 and HCO 3 Ϫ are the only known substrates for this enzyme. In view of the strong similarity between nitrite and HCO 3 Ϫ , having the same trigonal planar sp 2 orbital geometry and almost identical pK a values of their respective acids (3.4 and 3.5, respectively) and given that nitrite is known to bind to the active site of CA and to inhibit CO 2 hydration (18), we examined the possibility that CA could use nitrite as a substrate to generate nitric oxide (NO), a potent vasodilator (17, 36) .
A major part of NO generated by NO synthases (NOSs) becomes oxidized to nitrite, which is present in tissues at low micromolar levels (2) . Although nitrite is a natural end product of NO oxidation, recent work has shown that it may also function as an important source of NO in mammalian tissues (2, 45) , particularly in the cardiovascular system (11) . Several metal-containing enzymes, including globins (4, 37, 39) , xanthine oxidoreductase (32) , and mitochondrial aldehyde oxidase (26) , have been now identified that may effectively catalyze the one-electron reduction of nitrite to NO under hypoxic or anoxic conditions, where NO bioavailability also increases as cytochrome c oxidase becomes more reduced (35) . Although the complex coupling between low O 2 levels and nitrite conversion to NO in tissues has been extensively investigated, it is not yet fully understood how the end products of energy metabolism, particularly protons, regulate NO generation from nitrite. Earlier studies have demonstrated the nitrite-dependent formation of NO due to a pH decrease in the ischemic heart (48) and in aorta vessels (33) . Modin et al. (33) were the first to demonstrate in a seminal paper that physiological nitrite levels induce NO-dependent aortic vasodilation, particularly at acidic pH and independently of NOS activity. In this process, chemical (nonenzymatic) acidification of nitrite to NO appears too slow to play a major role at the low nitrite concentrations normally found in vivo (3), which suggests the existence of a specific catalyst. In this article we show that CA is able to readily generate high levels of vasoactive NO from nitrite at normal O 2 levels and in response to a decrease in pH. This novel physiological property of CA would contribute to regulate local blood flow in response to an increase in tissue metabolic activity before the O 2 tension falls below critical levels.
MATERIALS AND METHODS
Materials. Dorzolamide (Trusopt) was obtained from Merck Sharp & Dohme. Sodium nitrite (NaNO2), potassium nitrite (KNO2), purified CA (from bovine erythrocytes, containing the CAII isoform), norepinephrine (NE), acetylcholine, asymmetric dimethylarginine, ZnCl2, indomethacin, and acetazolamide were obtained from SigmaAldrich (St. Louis, MO). Purified CA was heat denatured at 100°C for 10 min. Apo-enzyme was prepared from purified CA as described (16) , dialyzed against milli-Q (Millipore) water, and liophylized. Adult male Wistar rats (10 -12 wk) were euthanized by decapitation and subsequent exsanguination as approved by The Danish Ministry of Justice (permission no. 2005/561Ϫ964). Tissues used for chemiluminescence were immediately excised, cut into small pieces, and rinsed from blood in ice-cold PBS, homogenized, and stored at Ϫ80°C. Arterial segments used for isometric tension recordings in microvascular myographs were isolated from the thoracic part of the aorta and were transferred to cold physiological saline solution (PSS, see Vasodilation experiments).
NO production measured by a NO electrode. NO levels were measured using a NO100 NO-sensitive electrode (Unisense, Aarhus, Denmark) in 10 mM phosphate buffer at 37°C in an open chamber with constant stirring. The response time of the electrode is ϳ10 s. Dorzolamide, KNO 2, and CA were applied as indicated in Fig. 1 . Solutions were prepared using milli-Q water. Traces were smoothed by averaging with a running average spanning 10 s. The maximal value for the trace obtained in this manner was used for further analyses. The electrode was calibrated by injecting anaerobic milli-Q water saturated with NO gas (2 mM) into anaerobic phosphate buffer at 37°C.
Kinetic analyses. Kinetic traces obtained with the NO electrode were analyzed by nonlinear least-squares fitting using the Table Curve 2D software (Systat, CA).
NO production measured by chemiluminescence. Experiments were carried out in a reaction vessel containing 10 mM phosphate buffer and KNO 2 preequilibrated and purged with N2 at 37°C, using a Sievers (Boulder, CO) Nitric Oxide Analyzer (NOA 280i) to detect NO in the gas phase at a sampling rate of 4 s Ϫ1 . Homogenized tissues (2 mg/ml), dorzolamide (250 M) and CA (10 M), were applied as indicated in Fig. 3 . Traces were smoothed by a running average spanning 10 s, and the maximal value obtained was used in further analyses. Calibration was done by fully reducing the known amounts of nitrite to NO with acidified potassium iodide, according to the manufacturer's instructions.
Vasodilation experiments. Experiments were carried out using a microvascular myograph (model no. 700 mo, Danish Myo Technology, Aarhus, Denmark) for isometric tension recordings. NE (0.020 M), NaNO 2 (10 M), purified CA from bovine erythrocytes (10 M), acetazolamide (100 M), and dorzolamide (250 M) were applied as indicated in Fig. 4 . PSS, containing (in mM) 119 NaCl, 25 NaHCO 3, 4.7 KCl, 1.18 KH2PO4, 1.17 MgSO4, 1.6 CaCl2, 0.026 EDTA, and 10 glucose, was equilibrated with 5% CO2-21% O2-74% N2, and mounting, normalization, and control of viability were performed as described previously (5, 34) . All segments were incubated with asymmetric dimethylarginine (300 M) and indomethacin (3 M) for 30 min (40) to inhibit endothelial NOS and cyclooxygenase, respectively. In selected experiments, aorta segments were incubated for 30 min with the selective CA inhibitors acetazolamide (100 M) or dorzolamide (250 M) alone or in combination with 1H- [1, 2, 4] oxadiazolo [4,3-a] quinoxalin-1-one (ODQ, 3 M) to inhibit soluble guanylate cyclase (9) . To induce a stable contraction of the arterial segments, NE was added to the myograph chamber after equilibrating with 1% O 2-5% CO2-94% N2 for 5 min. None of the inhibitors used influenced NE contraction. The active tension was defined as the level of contraction after the addition of NE subtracted by the level of contraction after the 30 min of equilibration in PSS after the normalization procedure. The tension after the addition of CA and nitrite was expressed as a percentage of the active tension.
Statistical analyses. All data are presented as means Ϯ SE with a significance level of P Ͻ 0.05, where n represents the number of individual experiments. Data were analyzed using an unpaired t-test by the SigmaPlot 11.0 software (Systat).
RESULTS
We used a NO-sensitive microelectrode to detect NO production in aerated phosphate buffer solutions following the addition of KNO 2 (100 M) in the absence and presence of purified CA (100 M) (Fig. 1, A and B) . We choose pH values The presence of CA alone increased maximal NO (P ϭ 0.003 at pH 7.2, and P ϭ 0.001 at pH 5.9). Adding dorzolamide resulted in a further increase in CA-dependent NO production (P ϭ 0.032 at pH 7.2, and P Ͻ 0.001 at pH 5.9). With CA present, the maximal production of NO from 100 M KNO2 in the absence of dorzolamide (light gray bars) was 13.6 Ϯ 2.4 nM at pH 7.2 and 95.8 Ϯ 15.7 nM at pH 5.9 (P Ͻ 0.001), whereas it was 83.2 Ϯ 33.1 nM at pH 7.2 and 205.1 Ϯ 23.1 nM at pH 5.9 (P ϭ 0.011) in the presence of dorzolamide (dark gray bars). D: control experiments showing maximal NO concentration (means Ϯ SE; n, number of individual experiments) measured upon addition of 100 M KNO2 to phosphate buffer (pH 5.9) containing 100 M of ZnCl2, heat-denatured CA, or Apo-CA as indicated in the absence (white and light gray bars) and presence (dark gray bars) of dorzolamide. Note the enlarged y-axis scale. *P Ͻ 0.05, significant difference. of 7.2 and 5.9 since they define the range from normal intracellular pH to tissue pH after 5-10 min of ischemia (48), respectively. As expected from its extremely low reaction rate (3), little NO was generated in the uncatalyzed reaction, whereas in the presence of CA, a significantly higher NO production was readily observed when adding nitrite, particularly at low pH (Fig. 1) . In an attempt to inhibit CA activity in the NO-generating reaction, we added dorzolamide (250 M), a specific inhibitor of the CO 2 hydration reaction catalyzed by CA (42) . This sulfonamide was chosen because of its high solubility and because it did not interfere with the NO electrode, in contrast to the less water-soluble acetazolamide, another specific inhibitor of CA (42) . To our surprise, the addition of dorzolamide increased the CA-catalyzed NO production to a significant extent (6-fold and 2-fold at pH 7.2 and 5.9, respectively, Fig. 1 ). The NO signal, which reflects the balance between NO production and NO consumption, was transient at pH 7.2 and prolonged at pH 5.9 (Fig. 1, A and B) , and the maximal NO signal was used in quantitative analyses (Fig. 1C) . The different profiles of the traces obtained at different pH values suggest that in the course of the reaction, intermediate or product species are consumed at high pH (Fig.  1A) or that nitrite is regenerated at low pH (Fig. 1B) , although the mechanism remains to be investigated. Heat-denatured or Apo-CA enzyme (100 M), Zn 2ϩ (added as ZnCl 2 , 100 M), or dorzolamide alone (250 M) did not cause any significant increase in NO production from 100 M nitrite (Fig. 1D) . Taken together, these data show that CA is able to react with nitrite to generate NO and that higher levels of NO are produced at low pH and in the presence of dorzolamide.
To determine the rates of NO production from nitrite in the CA-catalyzed reaction, we analyzed the kinetic traces collected using the NO electrode after adding nitrite to a final concentration of 100 M ( Fig. 2A) to CA solutions in the absence and presence of dorzolamide. Only the slowest response traces, indicating that complete mixing of the nitrite injected had occurred in the reaction chamber, were analyzed. As the reaction was studied under second-order conditions, i.e., at equivalent concentrations of enzyme and substrate (100 M), kinetic NO traces could be well fitted by a hyperbolic function (r 2 ϭ 0.981 Ϯ 0.024, n ϭ 20). A monoexponential function provided equally good fitting (r 2 ϭ 0.975 Ϯ 0.084, n ϭ 20) (Fig. 2A) , suggesting that the concentration of free substrate nitrite was in excess of enzyme-bound nitrite with the reaction taking place under pseudo first-order conditions. This finding is consistent with the low affinity of nitrite reported for CA (18) . The observed rates were significantly affected by pH but not dorzolamide (Fig. 2B) , and the apparent rate constants calculated from the values obtained in the monoexponential fitting with or without dorzolamide were (means Ϯ SE) Ͼ 547 Ϯ 116 M Ϫ1 ⅐s Ϫ1 at pH 7.2 and 84 Ϯ 42 M Ϫ1 ⅐s Ϫ1 at pH 5.9 (Fig. 2B ). Because the half-time of the reaction at pH 7.2 (t 1/2 , ϳ13 s) was equivalent to the response time of the electrode (ϳ10 s), the reaction at this pH occurs at rates faster than ϳ547 M Ϫ1 ⅐s
Ϫ1
. NO production at the low concentrations of enzyme and nitrite found in animal tissues (2, 27) was measured using a highly sensitive NO-chemiluminescence approach that detects NO in the gas phase when purging a reaction vessel with pure N 2 . In contrast to the experiments performed using the NO electrode, where NO is detected in solution, chemiluminescence that detects NO in the gas phase also monitors the production of N 2 O 3 (3). N 2 O 3 is formed in the course of the reaction here studied (see Eq. 2) and, when purged in the gas phase, completely homolyzes, yielding NO. As shown in Fig. 3A , nitrite-dependent NO production was observed when injecting purified CA at 10 M in the purge vessel of the NO analyzer containing nitrite (1, 5, and 10 M) in phosphate buffer at pH 7.2. This confirms the data of Fig. 1 and further shows that the reaction also occurs under anaerobic conditions. We then examined NO production following the injection of rat tissues homogenates in the purge vessel containing 100 M nitrite at pH 5.9. Under these conditions, numerous pathways of nitrite conversion to NO contribute to the NO detected. To discriminate between NO produced from nitrite by tissuespecific CAs and by other pathways, we examined whether dorzolamide had a significant effect on NO generation from each tissue by performing chemiluminescence analyses in the absence and in the presence of dorzolamide that specifically reacts with CA to enhance NO production from nitrite, as shown in Fig. 1 . NO production from nitrite could be detected in all tissues, in agreement with previous studies (8) , with blood, liver, and brain, showing a significant increase in the NO generated with dorzolamide present (Fig. 3, B and C) . In particular, the high-NO signal observed with blood with and without dorzolamide (Fig. 3, B and C) suggests that nitritedependent NO generation is in excess of the NO scavenging capacity of the hemoglobin present, consistent with previous Fig. 1 . B: observed rates (means Ϯ SE; n, number of individual experiments) calculated for each pH in the absence (white bars) and presence (gray bars) of dorzolamide were not significantly different (P ϭ 0.676 at pH 7.2, and P ϭ 0.393 at pH 5.9), and the data were therefore grouped according to pH (cross-hatched bars). The reaction rates at the 2 pH values with and without dorzolamide were significantly different (*P Ͻ 0.01). observations (4). As dorzolamide alone has no effect on NO generation (Fig. 1) , this enhancing effect of dorzolamide suggests that a functional CA able to catalyze the conversion of nitrite to NO is present in tissues (at least in blood, liver, and brain), although the relative role of CA isoforms and of other enzymes in the capability of different tissues to convert nitrite to NO under physiological conditions remains to be solved.
To verify that under physiological conditions of low nitrite (ϳ10 M) and high HCO 3 Ϫ (ϳ25 mM with 5% CO 2 , pH 7.4) that the NO produced by CA was vasoactive, we performed rat aortic ring bioassays at 1% O 2 and 5% CO 2 (Fig. 4, A and B) as previously described (5) . A concentration of nitrite of 10 M, close to that existing in aorta vessels (2) , is able to induce a ϳ50% vasodilation under these conditions (5) . The addition of exogenous CA (10 M) had only a slight effect on vasodilation in the absence of added nitrite, whereas the addition of CA and nitrite caused a significantly larger increase in vessel relaxation than that measured with either CA or nitrite alone (Fig. 4C) . The nitrite-dependent vasodilation of rat thoracic aorta segments increased significantly in the presence of acetazolamide and dorzolamide (Fig. 4C) . Conversely, vasodilation induced by the addition of CA and nitrite was significantly reduced with ODQ and acetazolamide or dorzolamide present, indicating that the relaxing effect observed is largely cGMP dependent. These data indicate that CA reacts with physiological levels of nitrite to generate vasoactive NO via the activation of soluble guanylate cyclase.
DISCUSSION
Since CA is a ubiquitous enzyme, its ability to produce NO from nitrite may be important in the control of nitrite-dependent signaling in general and in the control of local blood flow in particular. Most enzymes known to function as nitrite reductases are strictly dependent on severe hypoxic or anoxic conditions (45) with the exception of xanthine oxidase in the presence of NADH (45) and of hemoglobin, which generates NO from nitrite most efficiently at PO 2 close to its p50 (15, 21), although its physiological role has been questioned (5, 6, 19) . As shown here, CA is able to generate vasoactive NO from nitrite at high rates and with no strict requirement for low O 2 . This novel catalytic activity allows CA to translate an early signal of increased metabolic activity (i.e., a fall in local pH before O 2 falls below critical levels) into an increase in tissue O 2 supply not only by favoring hemoglobin O 2 unloading through the Bohr effect but also by generating vasoactive NO.
Given that the active metal Zn 2ϩ of CA does not sustain redox activity, this enzyme most likely functions as a nitrous anhydrase, with a reaction mechanism that is second order in nitrite and equivalent to the reverse of the CO 2 hydration shown in Eq. 1:
Where N 2 O 3 rapidly homolyzes into NO and NO 2 (3, 13) ,
The reaction mechanism reported in Eqs. 2 and 3 corresponds to the acidic disproportionation of nitrite involved in the acid-mediated and nitrite-dependent generation of NO reported in previous studies (33, 48) and that is shown here to be catalyzed by CA. Whereas purging by inert gases would shift the above equilibria to the right due to the irreversible homolysis of N 2 O 3 in the gas phase (3), in solution N 2 O 3 and NO are in equilibrium (K ϭ 2 ϫ 10 Ϫ5 M) (13) and the kinetics shown in Fig. 2 better approximate the approach to equilibrium achieved under physiological conditions.
The requirement for protons in the reaction in Eq. 2 explains why more product is generated at low pH (Fig. 1) . That the reaction rate becomes faster at high pH (Fig. 2) suggests that the anion nitrite (at high pH) participates more efficiently in catalysis and further indicates that CA is not a nitrite reductase, which increases reaction rate at low pH (15, 39) . Interestingly, the hydration of CO 2 is also faster at a high pH, as the Zn 2ϩ -bound hydroxide anion reacts more readily with CO 2 than Zn 2ϩ -bound water (27) . Fig. 3 . Chemiluminescence analyses of NO produced from nitrite by purified CA and by rat tissues at 37°C at a 4 s Ϫ1 sampling rate. A: NO production from addition of purified CA (10 M, final concentration) to the reaction chamber containing physiological levels of nitrite (1, 5, and 10 M KNO2) at pH 7.2. Injection of CA caused a NO production that was linearly dependent on the nitrite concentration present in the chamber. A, inset: NO traces following CA injections (indicated by arrows) at 3 different nitrite concentrations. B: representative NO traces following injections of rat whole blood lysates to the purge vessel containing 100 M KNO2 in 10 mM phosphate buffer (pH 5.9) in the absence (black) and in the presence (gray) of dorzolamide (250 M). C: maximal NO production (means Ϯ SE; n, number of individual experiments) following injections of rat tissue homogenates (2 mg/ml, final concentration) to the vessel containing 100 M KNO2 at pH 5.9 in the absence (white bars) and presence (gray bars) of dorzolamide (250 M). Measurements with and without dorzolamide were done in separate runs. All tissues added increased NO production from nitrite. In the presence of dorzolamide, NO production was enhanced in liver, whole blood, and brain homogenates (P ϭ 0.0150, P ϭ 0.0170, and P ϭ 0.0450, respectively). *P Ͻ 0.05, significant difference.
The yield of NO product but not its rate of formation increases in the presence of dorzolamide and acetazolamide. These two sulfonamide inhibitors of CA are commonly used therapeutic drugs (42) and bind tightly to the active site Zn 2ϩ to generate a tetrahedral complex that occupies the hydrophobic pocket where CO 2 binds. That dorzolamide prevents the hydration of CO 2 but not the dehydration of nitrite suggests that the two substrates bind to different groups in the active site and may provide a first indication on the possible mode of interaction between nitrite and CA. It is also possible that dorzolamide and acetazolamide may increase the affinity for the substrate nitrite by occupying nonproductive binding sites on the enzyme. Interestingly, the active sites of Cu 2ϩ bacterial nitrite reductase and of Zn 2ϩ mammalian CA are remarkably similar (41) , suggesting that similar amino acid residues may be involved in the binding of nitrite in the two enzymes, despite their different reaction mechanisms.
Earlier studies on CA have reported similar low binding affinities for nitrite (K I ϭ 63 mM) (18) , HCO 3 Ϫ (K D ϭ 70 mM) (31), and CO 2 (K D ϭ 100 mM) (24, 27) . Because of the low affinity of CA for any of these substrates, only a small fraction of the enzyme is bound to substrate under the conditions investigated here and in vivo, which leaves a large enzyme capacity available. Therefore, the proton-generating hydration of CO 2 and the proton-dependent generation of NO may occur simultaneously in vivo, whereby end products of both aerobic (CO 2 ) and anaerobic (H ϩ ) metabolism would increase the amount of NO formed from endogenous nitrite.
When local cellular activity suddenly increases, as it does upon the activation of muscle or neuronal cells, the major energy-generating pathway able to respond with comparable rapidity is glycolysis, which initially contributes almost all extra ATP produced. As a result, the local milieu will experience an initial temporary buildup of lactic acid and a concurrent decrease in pH, but no significant decrease in local PO 2 due to the release of O 2 from the hemoglobin (Bohr effect). Thus a local decrease in pH is the initial rapid signal of increased local metabolic activity or of inadequate perfusion. The resultant increase in the NO produced by CA from endogenous nitrite under conditions of low pH (Fig. 1B) would provide a rapid local vasodilation. The ability of CA to mediate a rapid vasodilation is supported by high-rate constants for the conversion of nitrite into NO (Ͼ547 and ϳ84 M Ϫ1 ⅐s Ϫ1 at pH 7.2 and 5.9, respectively, 37°C), which are much higher than those for hemoglobin (ϳ4.4 M Ϫ1 ⅐s Ϫ1 at pH 7.0, 37°C) (15) and myoglobin (ϳ12.4 M Ϫ1 ⅐s Ϫ1 at pH 7.4, 37°C) (39) . Furthermore, as CO 2 produced in the aerobic metabolism also decreases pH, NO production from CA could contribute to the maintenance of vasoactive NO levels also during normal oxygenation. Our finding that dorzolamide and acetazolamide increase CA-mediated production of vasoactive NO from nitrite (Fig. 4 ) may explain at least in part how systemic applications of acetazolamide increase blood flow in the brain (25) , lungs (14) , and retina (44) independently of NOS activity (23) . These vasoactive effects of acetazolamide and dorzolamide are largely dependent on the activity of soluble guanylate cyclase (Fig. 4C ), in agreement with previous results showing that nitrite vasoactivity is inhibited by ODQ (5, 33) . Whether the effects of acetazolamide linked to NO generation are part of its action in the treatment of acute mountain sickness (43) remains to be investigated. Asymmetric dimethylarginine (300 M) and indomethacin (3 M) were present to inhibit endothelial NO synthase and cyclooxygenase, respectively. The traces illustrate the relaxing effect of physiological levels of nitrite in the absence (continuous line) and presence (dashed line) of exogenous CA. C: degree (in %) of relaxation observed (means Ϯ SE, n ϭ 4 individual experiments) in the absence (control) and presence of acetazolamide or dorzolamide. *P Ͻ 0.05 and **P Ͻ 0.01, significant difference. Acetazolamide and dorzolamide caused a significant increase in nitrite-dependent relaxation both in the absence (P ϭ 0.0083 and P ϭ 0.0222, respectively, light gray bars) and presence (P ϭ 0.0234 and P ϭ 0.0346, respectively, dark gray bars) of added CA. ODQ (white bars, n ϭ 6) significantly decreased the degree of relaxation observed in the presence of added CA and nitrite (dark gray bars) either in the presence of acetazolamide (P Ͻ 0.001) or dorzolamide (P ϭ 0.0018).
The finding of different production of NO from nitrite in different tissues reflects the expression of tissue-specific CA isoforms with different catalytic activity and sensitivity to dorzolamide and the activation of other nitrite-reducing pathways under anaerobic conditions. The NO increase observed in the presence of dorzolamide (Fig. 3C) indicates that the CAdependent pathway of generation of NO from nitrite may be particularly active in blood, but also in liver and brain. Furthermore, both the CAI and CAII isoforms are present in the vessel wall (1) and may participate to intrinsic mechanisms of nitrite-induced vessel relaxation (5) . CA is expressed in a wide range of cell types, including capillary endothelial cells, glial cells, and erythrocytes, and is either soluble, intracellular, extracellular, or membrane bound (10, 27, 38) . The most active isoform CAII has a wide tissue distribution and is also the second most abundant protein in red blood cells, which is consistent with the large effect of dorzolamide on NO production shown in Fig. 3 , B and C. Less CA is present in the brain, in accordance with a reduced effect of dorzolamide (Fig. 3C) . The membrane-bound CAIV isoform is expressed mostly in lung capillaries and kidney epithelial cells and is less inhibited by dorzolamide, which might also have reduced the increase in NO formation due to dorzolamide (Fig. 3C) .
Because of its localization in blood circulation and neuronal tissue, the NO-generating activity of CA is potentially of key importance to the still poorly understood neurovascular coupling (28), i.e., the correlation between neuronal activity and vasodilation used in analyses of neuronal processing by blood O 2 level-dependent functional magnetic resonance imaging (BOLD-fMRI). Specifically, astrocytic glycolysis has recently been found to be a determining factor in the regulation of local blood flow in response to neuronal activity in the brain (12) . As NO is involved in numerous biological processes besides vasodilation, including mitochondrial O 2 consumption and cytoprotection (7, 11) , the novel NO-generating function of CA reported here widely extends the physiological role of this ubiquitous enzyme and the potential therapeutic applications of dorzolamide and acetazolamide.
